Pregabalin reduces the release of synaptic vesicles from cultured hippocampal neurons

Molecular Pharmacology
Kristina D MichevaStephen J Smith

Abstract

Pregabalin [S-[+]-3-isobutylGABA or (S)-3-(aminomethyl)-5-methylhexanoic acid, Lyrica] is an anticonvulsant and analgesic medication that is both structurally and pharmacologically related to gabapentin (Neurontin; Pfizer Inc., New York, NY). Previous studies have shown that pregabalin reduces the release of neurotransmitters in several in vitro preparations, although the molecular details of these effects are less clear. The present study was performed using living cultured rat hippocampal neurons with the synaptic vesicle fluorescent dye probe FM4-64 to determine details of the action of pregabalin to reduce neurotransmitter release. Our results indicate that pregabalin treatment, at concentrations that are therapeutically relevant, slightly but significantly reduces the emptying of neurotransmitter vesicles from presynaptic sites in living neurons. Dye release is reduced in both glutamic acid decarboxylase (GAD)-immunoreactive and GAD-negative (presumed glutamatergic) synaptic terminals. Furthermore, both calcium-dependent release and hyperosmotic (calcium-independent) dye release are reduced by pregabalin. The effects of pregabalin on dye release are masked in the presence of l-isoleucine, consistent with the fact that both...Continue Reading

References

Feb 15, 1993·European Journal of Pharmacology·D R HillG N Woodruff
Jul 2, 1998·Brain : a Journal of Neurology·R KöhlingF Oppel
Apr 15, 1999·Annual Review of Neuroscience·A B MacDermottS A Siegelbaum
Aug 9, 2002·European Journal of Pharmacology·Johannes A van HooftWytse J Wadman
Nov 29, 2002·The Journal of Physiology·Christopher R L Simkus, Christian Stricker
Jun 18, 2003·Seizure : the Journal of the British Epilepsy Association·Laura D Errante, Ognen A C Petroff
Aug 12, 2003·Nature Neuroscience·Kristina D MichevaStephen J Smith
Sep 10, 2004·The European Journal of Neuroscience·Mark O CunninghamRoland S G Jones
Jan 19, 2005·The European Journal of Neuroscience·Luz M SuárezJosé M Solís
Apr 2, 2005·Journal of Medicinal Chemistry·Thomas R BelliottiDavid J Wustrow

❮ Previous
Next ❯

Citations

May 3, 2011·Naunyn-Schmiedeberg's Archives of Pharmacology·M KammererT J Feuerstein
Dec 25, 2010·Der Schmerz·A J LedererA Sandner-Kiesling
Feb 12, 2013·Journal of Fluorescence·Oliver WelzelTeja W Groemer
Jul 2, 2008·Current Neurology and Neuroscience Reports·Michael A Rogawski, Carl W Bazil
Feb 27, 2008·Proceedings of the National Academy of Sciences of the United States of America·Jan HendrichAnnette C Dolphin
Feb 2, 2012·Epilepsia·Anna L MeehanSteven M Rothman
Dec 24, 2010·The Journal of Pharmacology and Experimental Therapeutics·Mariano N Di GuilmiOsvaldo D Uchitel
Feb 27, 2009·Clinical Drug Investigation·S ChiechioF Nicoletti
Sep 8, 2011·Journal of Anaesthesiology, Clinical Pharmacology·Dalim Kumar BaidyaMahesh Kumar Arora
Feb 14, 2014·The New England Journal of Medicine·Richard P AllenJohn W Winkelman
Feb 28, 2014·Journal of Anaesthesiology, Clinical Pharmacology·Anuj JainChetna Shamshery
Feb 4, 2014·Neuropharmacology·Ruggero G FarielloCarlo Farina
Sep 16, 2014·European Journal of Pharmacology·Parisa Hasanein, Saeed Shakeri
Apr 4, 2012·Expert Opinion on Drug Safety·Cory Toth
Apr 13, 2012·Current Medical Research and Opinion·Javier CabreraAndrew Clair
Mar 13, 2014·The Journal of Sexual Medicine·Mehtap BozkurtIsa Ozbey
Apr 4, 2007·Trends in Pharmacological Sciences·Anthony DaviesAnnette C Dolphin
Jan 16, 2007·Trends in Pharmacological Sciences·David J DooleyDouglas Feltner
Oct 1, 2009·Arthritis and Rheumatism·Richard E HarrisDaniel J Clauw
Dec 19, 2009·Hippocampus·A SamaraG Th Tsangaris
Aug 10, 2015·Neurotoxicology·Lorenzo Di Cesare MannelliCarla Ghelardini
May 23, 2015·Annals of Clinical and Translational Neurology·John A KesslerUNKNOWN VM202 DPN-II Study Group
Feb 6, 2013·Biochimica Et Biophysica Acta·David J Adams, Géza Berecki
Oct 16, 2012·Brain Research Bulletin·Carina WeissmannOsvaldo D Uchitel
Oct 28, 2008·Seizure : the Journal of the British Epilepsy Association·Antonio Gil-NagelTeresa Leon
May 18, 2010·The Journal of Pain : Official Journal of the American Pain Society·Michael TuchmanCharles P Taylor
Nov 8, 2011·Epilepsy & Behavior : E&B·Mehdi Ghasemi, Steven C Schachter
Oct 14, 2017·Cancer Chemotherapy and Pharmacology·Lorenzo Di Cesare MannelliCarla Ghelardini

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.